I
Il Dong Pharmaceutical Co Ltd
KRX:249420
Il Dong Pharmaceutical Co Ltd
KRX:249420
Price:
26 700
KRW
-1.48%
Market Closed
Market Cap:
₩844.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
I
|
Il Dong Pharmaceutical Co Ltd
KRX:249420
|
KR |
|
S
|
Shimano Inc
OTC:SMNNY
|
JP |
|
3
|
361 Degrees International Ltd
SWB:36L
|
CN |
Balance Sheet
Balance Sheet Decomposition
Il Dong Pharmaceutical Co Ltd
Il Dong Pharmaceutical Co Ltd
Balance Sheet Decomposition is not available for
Il Dong Pharmaceutical Co Ltd
Il Dong Pharmaceutical Co Ltd
Balance Sheet
Il Dong Pharmaceutical Co Ltd
Il Dong Pharmaceutical Co Ltd
Currency: KRW
| Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
19 905
|
39 943
|
75 937
|
89 959
|
85 564
|
135 586
|
52 146
|
53 258
|
72 267
|
|
| Cash |
37
|
29
|
13
|
23
|
34
|
34
|
34
|
34
|
34
|
|
| Cash Equivalents |
19 868
|
39 914
|
75 924
|
89 936
|
85 530
|
135 552
|
52 112
|
53 224
|
72 233
|
|
| Short-Term Investments |
0
|
300
|
1 695
|
600
|
600
|
19 095
|
26 600
|
9 500
|
2 605
|
|
| Total Receivables |
136 702
|
101 103
|
74 582
|
69 865
|
51 588
|
55 145
|
58 326
|
62 975
|
66 977
|
|
| Accounts Receivables |
127 603
|
94 405
|
70 456
|
63 632
|
49 511
|
52 216
|
54 249
|
56 066
|
44 634
|
|
| Other Receivables |
9 099
|
6 698
|
4 126
|
6 233
|
2 077
|
2 929
|
4 077
|
6 908
|
22 343
|
|
| Inventory |
61 202
|
59 983
|
53 200
|
69 744
|
89 227
|
82 587
|
98 249
|
84 623
|
87 939
|
|
| Other Current Assets |
892
|
3 694
|
5 041
|
3 199
|
6 264
|
9 137
|
46 714
|
25 325
|
17 203
|
|
| Total Current Assets |
218 700
|
205 025
|
210 456
|
233 367
|
233 243
|
301 550
|
282 035
|
235 681
|
246 991
|
|
| PP&E Net |
236 343
|
228 284
|
227 485
|
259 521
|
256 419
|
247 790
|
255 317
|
256 380
|
221 443
|
|
| PP&E Gross |
236 343
|
228 284
|
227 485
|
259 521
|
256 419
|
247 790
|
255 317
|
256 380
|
221 443
|
|
| Accumulated Depreciation |
83 689
|
98 267
|
113 471
|
132 054
|
148 990
|
167 676
|
186 365
|
190 968
|
194 902
|
|
| Intangible Assets |
76 041
|
99 089
|
88 169
|
69 608
|
63 072
|
61 100
|
41 594
|
36 584
|
28 832
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
5 527
|
5 527
|
5 527
|
5 527
|
|
| Note Receivable |
1 916
|
1 936
|
1 898
|
1 916
|
1 721
|
1 813
|
2 490
|
2 515
|
2 261
|
|
| Long-Term Investments |
135
|
9 598
|
9 962
|
11 575
|
21 665
|
22 422
|
21 250
|
18 987
|
23 729
|
|
| Other Long-Term Assets |
17 218
|
19 924
|
26 700
|
36 736
|
29 157
|
68 768
|
47 597
|
55 587
|
60 260
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
5 527
|
5 527
|
5 527
|
5 527
|
|
| Total Assets |
550 354
N/A
|
563 856
+2%
|
564 669
+0%
|
612 723
+9%
|
605 277
-1%
|
708 970
+17%
|
655 810
-7%
|
611 261
-7%
|
589 043
-4%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
30 981
|
26 777
|
20 583
|
39 764
|
35 988
|
38 334
|
46 099
|
50 250
|
47 616
|
|
| Accrued Liabilities |
26 436
|
25 211
|
30 014
|
29 618
|
24 480
|
38 275
|
36 850
|
37 937
|
36 442
|
|
| Short-Term Debt |
33 000
|
37 400
|
58 400
|
74 400
|
65 400
|
88 400
|
113 400
|
149 200
|
90 333
|
|
| Current Portion of Long-Term Debt |
33 400
|
48 000
|
36 000
|
36 336
|
26 956
|
52 412
|
40 607
|
37 162
|
47 590
|
|
| Other Current Liabilities |
18 711
|
20 025
|
17 901
|
31 724
|
32 186
|
146 718
|
79 334
|
39 681
|
53 987
|
|
| Total Current Liabilities |
142 528
|
157 413
|
162 897
|
211 843
|
185 010
|
364 141
|
316 290
|
314 230
|
275 967
|
|
| Long-Term Debt |
64 000
|
45 000
|
36 000
|
55 185
|
74 500
|
91 720
|
59 387
|
31 479
|
74 852
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
6
|
1
|
393
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
7 676
|
6 981
|
4 723
|
242
|
|
| Other Liabilities |
75 412
|
77 142
|
88 947
|
92 803
|
91 219
|
92 525
|
81 903
|
91 284
|
77 315
|
|
| Total Liabilities |
281 940
N/A
|
279 555
-1%
|
287 845
+3%
|
359 831
+25%
|
350 730
-3%
|
556 062
+59%
|
464 567
-16%
|
441 718
-5%
|
428 285
-3%
|
|
| Equity | ||||||||||
| Common Stock |
17 845
|
19 629
|
21 591
|
22 670
|
23 803
|
23 803
|
26 803
|
28 063
|
28 063
|
|
| Retained Earnings |
11 795
|
26 615
|
17 366
|
4 872
|
14 856
|
81 951
|
211 102
|
58 540
|
50 942
|
|
| Additional Paid In Capital |
238 947
|
238 947
|
238 947
|
238 947
|
209 645
|
210 262
|
377 287
|
173 359
|
173 327
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
830
|
3 532
|
6 609
|
1 112
|
1 445
|
28 957
|
12 607
|
|
| Treasury Stock |
123
|
186
|
249
|
322
|
365
|
365
|
365
|
2 307
|
2 307
|
|
| Other Equity |
50
|
704
|
0
|
0
|
0
|
47
|
66
|
11
|
11
|
|
| Total Equity |
268 414
N/A
|
284 301
+6%
|
276 825
-3%
|
252 892
-9%
|
254 547
+1%
|
152 909
-40%
|
191 244
+25%
|
169 543
-11%
|
160 758
-5%
|
|
| Total Liabilities & Equity |
550 354
N/A
|
563 856
+2%
|
564 669
+0%
|
612 723
+9%
|
605 277
-1%
|
708 970
+17%
|
655 810
-7%
|
611 261
-7%
|
589 043
-4%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
24
|
24
|
24
|
24
|
24
|
24
|
27
|
28
|
28
|
|
Switch to:
Switch to:
See Also
Discover More
